| Ms Alisha N Orage Freeman, APRN | |
|
1510 Ribaut Rd, Port Royal, SC 29935-1403 | |
| (843) 770-0676 | |
| Not Available |
| Full Name | Ms Alisha N Orage Freeman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1510 Ribaut Rd, Port Royal, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891193371 | NPI | - | NPPES |
| NP3083 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APN-TP 19211 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Doctors Care, Pa | 6204731300 | 187 |
News Archive
Threshold Pharmaceuticals, Inc., today reported financial results for the first quarter ended March 31, 2010.
Cornell University researchers have developed a reliable method to distinguish memory declines associated with healthy aging from the more-serious memory disorders years before obvious symptoms emerge. The method also allows research to accurately predict who is more likely to develop cognitive impairment without expensive tests or invasive procedures.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that detects the early development of emphysema - well before symptoms occur - may someday also be offered.
› Verified 2 days ago
| Entity Name | Doctors Care, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366499048 PECOS PAC ID: 6204731300 Enrollment ID: O20040112000069 |
News Archive
Threshold Pharmaceuticals, Inc., today reported financial results for the first quarter ended March 31, 2010.
Cornell University researchers have developed a reliable method to distinguish memory declines associated with healthy aging from the more-serious memory disorders years before obvious symptoms emerge. The method also allows research to accurately predict who is more likely to develop cognitive impairment without expensive tests or invasive procedures.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that detects the early development of emphysema - well before symptoms occur - may someday also be offered.
› Verified 2 days ago
| Entity Name | Sc House Calls Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518048859 PECOS PAC ID: 6800994807 Enrollment ID: O20070613000821 |
News Archive
Threshold Pharmaceuticals, Inc., today reported financial results for the first quarter ended March 31, 2010.
Cornell University researchers have developed a reliable method to distinguish memory declines associated with healthy aging from the more-serious memory disorders years before obvious symptoms emerge. The method also allows research to accurately predict who is more likely to develop cognitive impairment without expensive tests or invasive procedures.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that detects the early development of emphysema - well before symptoms occur - may someday also be offered.
› Verified 2 days ago
| Entity Name | Beaufort Jasper Hampton Comprehensive Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649276148 PECOS PAC ID: 5597675728 Enrollment ID: O20160427001262 |
News Archive
Threshold Pharmaceuticals, Inc., today reported financial results for the first quarter ended March 31, 2010.
Cornell University researchers have developed a reliable method to distinguish memory declines associated with healthy aging from the more-serious memory disorders years before obvious symptoms emerge. The method also allows research to accurately predict who is more likely to develop cognitive impairment without expensive tests or invasive procedures.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that detects the early development of emphysema - well before symptoms occur - may someday also be offered.
› Verified 2 days ago
| Entity Name | Physicians Services Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700357076 PECOS PAC ID: 7618215690 Enrollment ID: O20190218001221 |
News Archive
Threshold Pharmaceuticals, Inc., today reported financial results for the first quarter ended March 31, 2010.
Cornell University researchers have developed a reliable method to distinguish memory declines associated with healthy aging from the more-serious memory disorders years before obvious symptoms emerge. The method also allows research to accurately predict who is more likely to develop cognitive impairment without expensive tests or invasive procedures.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that detects the early development of emphysema - well before symptoms occur - may someday also be offered.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Alisha N Orage Freeman, APRN Agape Senior Primary Care Inc, 1053 Center Street, West Columbia, SC 29169-6749 Ph: (803) 726-2350 | Ms Alisha N Orage Freeman, APRN 1510 Ribaut Rd, Port Royal, SC 29935-1403 Ph: (843) 770-0676 |
News Archive
Threshold Pharmaceuticals, Inc., today reported financial results for the first quarter ended March 31, 2010.
Cornell University researchers have developed a reliable method to distinguish memory declines associated with healthy aging from the more-serious memory disorders years before obvious symptoms emerge. The method also allows research to accurately predict who is more likely to develop cognitive impairment without expensive tests or invasive procedures.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that detects the early development of emphysema - well before symptoms occur - may someday also be offered.
› Verified 2 days ago
Miss Monica Walker, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1510 Ribaut Rd, Port Royal, SC 29935 Phone: 843-770-0676 | |
Kalysta T Pioggia, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1510 South Ribaut Rd, Port Royal, SC 29935 Phone: 843-770-0676 | |
Doreen Mary Massey, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1510 Ribaut Rd, Port Royal, SC 29935 Phone: 843-770-0676 | |
Mr. Robert Louis Carter Ii, RN, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1875 N Paris Ave, Port Royal, SC 29935 Phone: 843-522-3870 Fax: 843-522-0691 | |
Mr. Brian Joseph Burger, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1833 N Paris Ave, Port Royal, SC 29935 Phone: 843-522-1420 Fax: 843-522-1460 | |
Dr. Melissa Rose Mesenburg, DNP, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1110 13th St, Port Royal, SC 29935 Phone: 843-525-6257 | |
Kathryn Mitchell Jones, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1680b Ribaut Road, Port Royal, SC 29935 Phone: 843-521-9879 Fax: 843-521-9879 |